Browse the corpus

REFERENCES American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity, “Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes,” Diabetes Care , 2004, 27(2):596-601. [PubMed 14747245 ] American Geriatrics Society 2012 Beers Criteria Update Expert Panel, "American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults," J Am Geriatr Soc , 2012, 60(4):616-31. [PubMed 22376048 ] Barbee JG, Conrad EJ, and Jamhour NJ, “Aripiprazole Augmentation in Treatment-Resistant Depression,” Ann Clin Psychiatry , 2004, 16(4):189-94. [PubMed 15702566 ] Barzman DH, DelBello MP, Kowatch RA, et al “The Effectiveness and Tolerability of Aripiprazole for Pediatric Bipolar Disorders: A Retrospective Chart Review,” J Child Adolesc Psychopharmacol , 2004, 14(4):593-600. [PubMed 15662152 ] Bastiaens L, "A Non-Randomized, Open Study With Aripiprazole and Ziprasidone for the Treatment of Aggressive Behavior in Youth in a Community Clinic," Community Ment Health J , 2009, 45(1):73-7. [PubMed 18597173 ] Biederman J, McDonnell MA, Wozniak, et al, “Aripiprazole in the Treatment of Pediatric Bipolar Disorder: A Systematic Chart Review,” CNS Spectr , 2005, 10(2):141-8. [PubMed 15685125 ] Burris KD, Molski TF, Xu C, et al, “Aripiprazole, A Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors,” J Pharmacol Exp Ther , 2002, 302(1):381-9. [PubMed 12065741 ] Davis JM, Chen N, and Glick ID, “A Meta-Analysis of the Efficacy of Second-Generation Antipsychotics,” Arch Gen Psychiatry , 2003, 60(6):553-64. [PubMed 12796218 ] Dixon L, Perkins D, and Calmes C, Guideline Watch (September 2009): Practice Guideline for the Treatment of Schizophrenia , Arlington, Va: American Psychiatric Association, 2009. Available at file://www.psychiatryonline.com/content.aspx?aid=501001 Duane DD, “Aripiprazole in Childhood and Adolescence for Tourette Syndrome,” J Child Neurol , 2006, 21(4):358. [PubMed 16900939 ] Durkin JP, “Aripiprazole in the Treatment of Bipolar Disorder in Children and Adolescents,” J Child Adolesc Psychopharmacol , 2004, 14(4):505-6. [PubMed 15662141 ]

Dixon L, Perkins D, and Calmes C, Guideline Watch (September 2009): Practice Guideline for the Treatment of Schizophrenia , Arlington, Va: American Psychiatric Association, 2009. Available at file://www.psychiatryonline.com/content.aspx?aid=501001 Duane DD, “Aripiprazole in Childhood and Adolescence for Tourette Syndrome,” J Child Neurol , 2006, 21(4):358. [PubMed 16900939 ] Durkin JP, “Aripiprazole in the Treatment of Bipolar Disorder in Children and Adolescents,” J Child Adolesc Psychopharmacol , 2004, 14(4):505-6. [PubMed 15662141 ] Findling RL, Kauffman R, Sallee FR, et al, "An Open-Label Study of Aripiprazole: Pharmacokinetics, Tolerability, and Effectiveness in Children and Adolescents With Conduct Disorder," J Child Adolesc Psychopharmacol , 2009, 19(4):431-9. [PubMed 19702495 ] Gill SS, Bronskill SE, Normand SL, et al, “Antipsychotic Drug Use and Mortality in Older Adults With Dementia,” Ann Intern Med , 2007, 146(11):775-86. [PubMed 17548409 ] Hellerstein DJ, “Aripiprazole as an Adjunctive Treatment for Refractory Major Depression,” Prog Neuropsychopharmacol Biol Psychiatry , 2004, 28(8):1347-8. [PubMed 15588762 ] Inoue A, Miki S, Seto M, et al, “Aripiprazole, A Novel Antipsychotic Drug, Inhibits Quinpirole-Evoked GTPase Activity But Does Not Up-Regulate Dopamine D2 Receptor Following Repeated Treatment in the Rat Striatal Slices,” Eur J Pharmacol , 1997, 321(1):105-11. [PubMed 9083792 ] Jordan S, Koprivica V, Chen R, et al, “The Antipsychotic Aripiprazole Is a Potent, Partial Agonist at the Human 5-HT(1A) Receptor,” Eur J Pharmacol , 2002, 441(3):137-40. [PubMed 12063084 ] Kane JM, Carson WH, Saha AR, et al, “Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective Disorder,” J Clin Psychiatry , 2002, 63(9):763-71. [PubMed 12363115 ] Ketter TA, Wang PW, Chandler RA, et al, “Adjunctive Aripiprazole in Treatment-Resistant Bipolar Depression,” Ann Clin Psychiatry , 2006, 18(3):169-72. [PubMed 16923655 ] Lawler CP, Prioleau C, Lewis MM, et al, “Interactions of the Novel Antipsychotic Aripiprazole (OPC-14597) With Dopamine and Serotonin Receptor Subtypes,” Neuropsychopharmacology , 1999, 20(6):612-27. [PubMed 10327430 ] Lutz UC, Hiemke C, Wiatr G, et al, “Aripiprazole in Pregnancy and Lactation: A Case Report,” J Clin Psychopharmacol , 2010. 30(2):204-5. [PubMed 20520299 ]

Lawler CP, Prioleau C, Lewis MM, et al, “Interactions of the Novel Antipsychotic Aripiprazole (OPC-14597) With Dopamine and Serotonin Receptor Subtypes,” Neuropsychopharmacology , 1999, 20(6):612-27. [PubMed 10327430 ] Lutz UC, Hiemke C, Wiatr G, et al, “Aripiprazole in Pregnancy and Lactation: A Case Report,” J Clin Psychopharmacol , 2010. 30(2):204-5. [PubMed 20520299 ] Matsubayashi H, Amano T, and Sasa M, “Inhibition by Aripiprazole of Dopaminergic Inputs to Striatal Neurons From Substantia Nigra,” Psychopharmacology (Berl), 1999, 146(2):139-43. McGavin JK and Goa KL, “Aripiprazole,” CNS Drugs , 2002, 16(11):779-86. [PubMed 12383035 ] Mendhekar DN, Sunder KR, and Andrade C, “Aripiprazole Use in a Pregnant Schizoaffective Woman,” Bipolar Disord , 2006, 8(3):299-300. [PubMed 16696834 ] Mervak B, Collins J, and Valenstein M, “Case Report of Aripiprazole Usage During Pregnancy,” Arch Womens Ment Health , 2008, 11(3):249-50. [PubMed 18581041 ] Moore TA, “Schizophrenia Treatment Guidelines in the United States,” Clin Schizophr Relat Psychoses , 2011, 5(1):40-9. [PubMed 21459738 ] National Institute for Health and Clinical Excellence (NICE), National Collaborating Centre for Mental Health , “Schizophrenia. Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Updated),” National Clinical Practice Guideline Number 82, 2009:1-399. Available at www.nice.org.uk/cg082 Papakostas GI, Petersen TJ, Kinrys G, et al, “Aripiprazole Augmentation of Selective Serotonin Reuptake Inhibitors for Treatment-Resistant Major Depressive Disorder,” J Clin Psychiatry , 2005, 66(10):1326-30. [PubMed 16259548 ] Patkar AA, Peindl K, Mago R, et al, “An Open-Label, Rater-Blinded, Augmentation Study of Aripiprazole in Treatment-Resistant Depression,” Prim Care Companion J Clin Psychiatry , 2006, 8(2):82-7. [PubMed 16862232 ] Rabins PV, Blacker D, Rovner BW, et al, “American Psychiatric Association Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias. Second Edition,” Am J Psychiatry , 2007, 164(12 Suppl):5-56. Available at file://psychiatryonline.org/guidelines.aspx [PubMed 18340692 ] Rugino TA and Janvier YM, “Aripiprazole in Children And Adolescents: Clinical Experience,” J Child Neurol , 2005, 20(7):603-10. [PubMed 16159529 ]

Rabins PV, Blacker D, Rovner BW, et al, “American Psychiatric Association Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias. Second Edition,” Am J Psychiatry , 2007, 164(12 Suppl):5-56. Available at file://psychiatryonline.org/guidelines.aspx [PubMed 18340692 ] Rugino TA and Janvier YM, “Aripiprazole in Children And Adolescents: Clinical Experience,” J Child Neurol , 2005, 20(7):603-10. [PubMed 16159529 ] Schneeweiss S, Setoguchi S, Brookhart A, et al, “Risk of Death Associated With the Use of Conventional Versus Atypical Antipsychotic Drugs Among Elderly Patients,” CMAJ , 2007, 176(5): 627-32. [PubMed 17325327 ] Schlotterbeck P, Leube D, Kircher T, et al, “Aripiprazole in Human Milk,” Int J Neuropsychopharmacol , 2007, 10(3):433. [PubMed 17291382 ] Schneider LS, Tariot PN, Dagerman KS, et al, “Effectiveness of Atypical Antipsychotic Drugs in Patients With Alzheimer's Disease,” N Engl J Med , 2006, 355(15):1525-38. [PubMed 17035647 ] Simon JS and Nemeroff CB, “Aripiprazole Augmentation of Antidepressants for the Treatment of Partially Responding and Nonresponding Patients With Major Depressive Disorder,” J Clin Psychiatry , 2005, 66(10):1216-20. [PubMed 16259533 ] Stigler KA, Posey DJ, and McDougle CJ, “Aripiprazole for Maladaptive Behavior in Pervasive Developmental Disorders,” J Child Adolesc Psychopharmacol , 2004, 14(3):455-63. [PubMed 15650503 ] Suppes T, Dennehy EB, Hirschfeld RMA, et al, “The Texas Implementation of Medication Algorithms: Update to the Algorithms for the Treatment of Bipolar I Disorder,” J Clin Psychiatry , 2005, 66(7):870-86. [PubMed 16013903 ] Worthington JJ 3rd, Kinrys G, Wygant LE, et al, “Aripiprazole as an Augmentor of Selective Serotonin Reuptake Inhibitors in Depression and Anxiety Disorder Patients,” Int Clin Psychopharmacol , 2005, 20(1):9-11. [PubMed 15602109 ] Yonkers KA, Wisner KL, Stewart DE, et al, “The Management of Depression During Pregnancy: A Report From the American Psychiatric Association and the American College of Obstetricians and Gynecologists,” Obstet Gynecol , 2009, 114(3):703-13. [PubMed 19701065 ] Yoo HK, Kim JY, Kim CY. “A Pilot Study of Aripiprazole in Children and Adolescents With Tourette's Disorder,” J Child Adolesc Psychopharmacol , 2006, 16(4):505-6. [PubMed 16958578 ]

Yonkers KA, Wisner KL, Stewart DE, et al, “The Management of Depression During Pregnancy: A Report From the American Psychiatric Association and the American College of Obstetricians and Gynecologists,” Obstet Gynecol , 2009, 114(3):703-13. [PubMed 19701065 ] Yoo HK, Kim JY, Kim CY. “A Pilot Study of Aripiprazole in Children and Adolescents With Tourette's Disorder,” J Child Adolesc Psychopharmacol , 2006, 16(4):505-6. [PubMed 16958578 ] Yoo HK, Lee JS, Paik KW, et al, “Open-label Study Comparing the Efficacy and Tolerability of Aripiprazole and Haloperidol in the Treatment of Pediatric Tic Disorders,” Eur Child Adolesc Psychiatry , 2011, 20(3):127-35. [PubMed 21188439 ] Topic 8786 Version 46.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [1104-122.72.76.133-9E6425AB09-S244013.14]